资源描述：
《恶性胸腹水患者热疗联合腔内化疗的疗效及护理研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、恶性胸腹水患者热疗联合腔内化疗的疗效及护理研究［摘要］目的：探讨热疗联合腔内化疗治疗癌症患者恶性胸腹水疗效及护理策略。方法：对已确诊的25例恶性肿瘤引起的胸腹水患者，釆取胸腹腔积液引流后行腔内化疗，并联合局部热疗，治疗前进行心理护理及相应准备工作，定期巡视密切观察患者情况，加强引流、热疗及不良反应的护理。结果：25例患者治疗后总有效率为84.0%,生活质量改善率为80.0%,治疗后仅1例浅II度烫伤患者，经对症护理后痊愈，无其他严重不良反应发生。结论：热疗联合腔内化疗治疗癌症患者恶性胸腹水效果好，治疗中合理的护理策略、舒适的护理可减少热疗联合
2、化疗不良反应的发生，改善患者生活质量。［关键词］热疗；化疗；胸腹水；疗效；护理［中图分类号］R473.73［文献标识码］A［文章编号］1673-7210(2011)12(a)-126-02NursingcareandefficacystudyforpatientswithmalignantpleuralandabdominaleffusiontreatedbyperfusionchemotherapycombinedwiththermotherapyHUANGLichuni,CHENGYumei2,CHENHongl,LIUYuel,DING
3、Yunxial,LIYil,WANGYonggangl,LIYinghuall.DepartmentofOncology,KunmingGeneralHospitalofChengduMilitaryCommandofPLA,YunnanProvince,Kunming650032,China;2.TheFirstRetiredCadresinBeijiaochang,KunmingGeneralHospitalofChengduMilitaryCommandofPLA,YunnanProvinee,Kunming650032,China[A
4、bstract]Objective:Toinvestigatetheeffectandnursingcareduringperfusionchemotherapycombinedwiththermotherapyinthetreatmentofpatientswithmalignantpleuralandabdominaleffusion.Methods:25patientswithmalignantpleuralandabdominaleffusionweretreatedbydrainage,perfusionchemotherapyan
5、dthermotherapy・Psychologicalcareandpreparationsweretakenbeforetreatment,duringdrainageandthermotherapy,attentionswerepaidtothesituationofpatientsregularly・Results:Thetotalrecoveryof25patientswas84.0%,andthequalityoflifeimprovementratewas80.0%,onlyonepatientscaldedduringther
6、motherapycureandrecoveredaftersymptomaticcare・Conclusion:Thetreatmentofperfusionchemotherapycombinedwiththermotherapyinpatientswithmalignantpleuralandabdominaleffusionhasasignificanteffect;thereasonableandcozycarecandeeplyreducetheincidenceofpostoperativecomplicationduringt
7、hetreatment,andpromoterecoveryofpatients.[Keywords]Thermotherapy;Chemotherapy;Pleuralandabdominaleffusion;Nursingcare恶性胸腹腔积液是一些晚期癌症常见的并发症，肺癌、胃癌、肠癌等肿瘤患者晚期均可能出现胸腹腔积液，预后往往较差，甚至危及患者生命⑴。单纯的引流联合化疗治疗效果有限⑵，但随着热疗联合腹腔化疗的出现，情况有所改观，热疗可与化疗起到协同作用，且可以减轻化疗的不良反应[3]。我院于2002~2007年对25例晚期癌症伴恶性胸
8、腹腔积液患者行热疗联合腔内化疗，效果理想，现报道如下：1资料与方法1.1一般资料选取我科25例晚期癌症伴恶性胸腹腔积液患者,其中，男13例，女12例；年龄33~65
